Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Wengen Alberta, LP LAUR Laureate Education, Inc. 13D/A 9.83% 2y
Common Property Trust NRC Nrc Health 13D/A 16.2% 2y
WHITMORE BRADFORD T SLSN Solesence, Inc. 13D/A 71.5% 2y
BIOTECHNOLOGY VALUE FUND L P MLTX MoonLake Immunotherapeutics 13D/A 34.6% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC MMU Western Asset Managed Municipals Fund Inc. 13G/A 10.24% 2y
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO RNTX Rein Therapeutics, Inc. 13G 6.2% 2y
WOLVERINE ASSET MANAGEMENT LLC ARIZ Arisz Acquisition Corp. Common Stock 13G/A 0% 2y
Ron Shemer PKBK Parke Bancorp, Inc. 13D 5.17% 2y
Samsara BioCapital, L.P. VTVT vTv Therapeutics Inc. 13D 10.4% 2y
European Lithium Limited CRML Critical Metals Corp. 13D 83.8% 2y
BAKER BROS. ADVISORS LP VTVT vTv Therapeutics Inc. 13D 4.99% 2y
KERBER WILLIAM XAVIER III PDYN Palladyne AI Corp. 13D 8.1% 2y
MILLENNIUM MANAGEMENT LLC ALT Altimmune, Inc. 13G 5.4% 2y
GRIFFIN ASSET MANAGEMENT, INC. AXDX Accelerate Diagnostics, Inc. 13G 8.4% 2y
Exor N.V. CLVT Clarivate PLC 13D/A 10.1% 2y
Innoviva, Inc. ARMP Armata Pharmaceuticals, Inc. 13D/A 85.3% 2y
Karpus Management, Inc. NEA Nuveen AMT-Free Quality Municipal Income Fund 13D/A 8.06% 2y
OH Cypress Aggregator, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 7.4% 2y
RS Fund LP NURO NeuroMetrix, Inc. Common Stock 13D/A 9.9% 2y
Fund 1 Investments, LLC TLYS Tilly's, Inc. 13D/A 32.39% 2y
Karpus Management, Inc. NRK Nuveen New York Amt-Free Quality Municipal Income Fund 13D/A 23% 2y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 7.1% 2y
180 Degree Capital Corp. SCOR Comscore, Inc. 13D/A 7.2% 2y
New York Life Investment Management LLC BBAG J.P. Morgan Exchange-Traded Fund Trust 13G/A 21.91% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 7.62% 2y
Lior Susan OWLT Owlet, Inc. 13D/A 48.9% 2y
Jay Lichter, Ph.D. (“Lichter”) JANX Janux Therapeutics, Inc. 13D/A 17.1% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 3.35% 2y
Intercontinental Exchange, Inc. BKKT Bakkt, Inc. 13D/A 56.6% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 7.44% 2y
JAB BevCo B.V. KDP Keurig Dr Pepper Inc. 13D/A 27.6% 2y
Mithaq Capital SPC PLCE Childrens Place, Inc. 13D/A 56.1% 2y
Divisadero Street Capital Management, LP LPSN Liveperson Inc 13G 6.2% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 16.45% 2y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 5.98% 2y
New York Life Investment Management LLC BAB Invesco Exchange-Traded Fund Trust II 13G/A 0% 2y
TPG GP A, LLC TPG TPG Inc. 13D/A 74.8% 2y
DGP Co., Ltd. XCUR Exicure, Inc. 13D/A 35.4% 2y
Divisadero Street Capital Management, LP ZIMV ZimVie Inc. Common Stock 13G 6% 2y
STONEHILL CAPITAL MANAGEMENT LLC MDRX Veradigm Inc. Common Stock 13G 19.5% 2y
Chicago Capital, LLC KRNT Kornit Digital Ltd. 13G 5.17% 2y
Focused Compounding Fund, LP PRKA Parks America, Inc 13D/A 38.44% 2y
MILLENNIUM MANAGEMENT LLC AHR American Healthcare REIT, Inc. 13G 5.3% 2y
GLAZER CAPITAL, LLC TGH Textainer Group Holdings limited 13G 6.34% 2y
Venrock Healthcare Capital Partners III, L.P. IPSC Century Therapeutics, Inc. 13G 5.4% 2y
D. E. Shaw & Co., L.P. AAP Advance Auto Parts Inc 13G/A 6.4% 2y
Boswell Prayer Ltd PTHS Pelthos Therapeutics Inc. 13G 8.2% 2y
Manmohan Patel TVGN Tevogen Inc. 13G 5.6% 2y
The Raine Group LLC BODI Beachbody Company, Inc. 13D/A 18.4% 2y
Gary M. Katz SQFT Presidio Property Trust, Inc. 13D 5.8% 2y